Blog: You, us, everyone

Welcome to our blog – a place to discuss and exchange thoughts and ideas about iX-7 Asset Management SA, the stock markets and all matters relating to wealth management.


Article
Saturday, October 15, 2022 by Christoph.Schmid|Comment 0
within category ARNM,Biotechnology
Deux bonnes nouvelles pour le laboratoire. Les autorités de santé ont approuvé les vaccins de rappel adaptés au variant Omicron pour les enfants dès cinq ans. Et la pharma annonce s'associer à Merck pour développer et vendre un vaccin ARNM contre le cancer.
Comments
Not commented yet? Be the first to post a comment.
Current pageTotal pages 0
Comments per page
select
Add a comment
Author:
Email: Help
Related articles
Tuesday, July 1, 2025
Alcon AG is a leading global medical company solely focused on eye care. Headquartered in Geneva, Switzerland, Alcon operates in two primary segments: Surgical (advanced equipment and consumables for…
More …
Sunday, June 29, 2025
AstraZeneca PLC (Ticker: AZN.L / AZN) is a British-Swedish multinational pharmaceutical and biotechnology company, and one of the largest and most innovative players in the global healthcare sector. …
More …
Monday, February 16, 2015
Speed read New growth in cases: Measles was officially eliminated in the Western world in the late 1990s, but a growing number of cases have been reported i…
More …
TAKE IT TO THE NEXT LEVEL:
HOME PAGE SUBSCRIPTIONS Private Policy
AMC - iX-7 Asset Management SA DIGITAL AGE TRANSFORMATION CHECK YOUR RISK-PROFILE Disclaimer
HOW DOES IT WORK DEMO PORTFOLIO Terms of Use
FEATURES LET'S BUILD YOUR PORTFOLIO GDPR
INSTITUTIONAL OFFER MANAGE YOUR ASSETS Contact
CONCEPT Login
BLOG
iX-7 Asset Management SA, access to financial information is a right. Knowledge is power.